Aardvark Therapeutics, Inc. (AARD)
13.12
-0.10
(-0.76%)
USD |
NASDAQ |
Dec 31, 16:00
13.10
-0.02
(-0.15%)
After-Hours: 20:00
Aardvark Therapeutics Total Liabilities (Quarterly): 10.85M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Insmed, Inc. | 1.415B |
| Immunic, Inc. | 30.20M |
| Soleno Therapeutics, Inc. | 105.09M |
| Rhythm Pharmaceuticals, Inc. | 358.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.23M |
| Shareholders Equity (Quarterly) | 122.38M |
| Debt to Equity Ratio | 0.0045 |
| Current Ratio | 12.03 |
| Net Debt Paydown Yield | -0.04% |